Research and analysis

Genetically Modified Organisms: Sanofi Pasteur, Inc. (24/R56/01)

Inviting representation on an application from Sanofi Pasteur, Inc. to release a genetically modified organism, reference 24/R56/01.

From:
Department for Environment, Food & Rural Affairs
Published
11 January 2024

Documents

Parts A1 to A6: Application for consent to release a GMO – organisms other than higher plants

PDF, 814 KB, 53 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part B: Information about the release application to be included on the public register

PDF, 244 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Sanofi Pasteur Inc. has applied to Defra for consent to perform a deliberate release of genetically modified Respiratory Syncytial Virus for clinical research and development purposes.

We invite representations on any risks of damage being caused to the environment by the release applied for in this application (reference 24/R56/01).  

You can make representation by:

  • writing to the GM Team, Department for Environment, Food and Rural Affairs, Second Floor, Seacole Building, Marsham Street, London SW1P 4DF, stating the application reference number

  • emailing us at gm-regulation@defra.gov.uk include the application reference number in the email title

Representations will need to be received by 5 March 2024.  Any representations made after this date will not be considered. If you wish your representation to remain confidential, please state this clearly when submitting it. We will acknowledge receipt of representations, but we do not reply to individual representations.

Published 11 January 2024

Related content